A randomized placebo‐controlled trial of an NMDA receptor antagonist in sleep‐disordered breathing
STEFAN TORVALDSSON(Sahlgrenska University Hospital), Jan Hedner(Sahlgrenska University Hospital), Ludger Grote(Sahlgrenska University Hospital), Yüksel Peker(University of Gothenburg), Hans Basun(Uppsala University)
Cited by 18
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea
|Circulation|2003|929
Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea: A 7-Year Follow-up
|American Journal of Respiratory and Critical Care Medicine|2002|787
Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial
|American Journal of Respiratory and Critical Care Medicine|2016|730
Comparison of detrended fluctuation analysis and spectral analysis for heart rate variability in sleep and sleep apnea
|IEEE Transactions on Biomedical Engineering|2003|489